An antibody-based biomarker discovery method by mass spectrometry sequencing of complementarity determining regions
Open Access
- 24 November 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Analytical and Bioanalytical Chemistry
- Vol. 399 (3), 1081-1091
- https://doi.org/10.1007/s00216-010-4361-9
Abstract
Autoantibodies are increasingly used as biomarkers in the detection of autoimmune disorders and cancer. Disease specific antibodies are generally detected by their binding to specific antigens. As an alternative approach, we propose to identify specific complementarity determining regions (CDR) of IgG that relate to an autoimmune disorder or cancer instead of the specific antigen(s). In this manuscript, we tested the technical feasibility to detect and identify CDRs of specific antibodies by mass spectrometry. We used a commercial pooled IgG preparation as well as purified serum IgG fractions that were spiked with different amounts of a fully human monoclonal antibody (adalimumab). These samples were enzymatically digested and analyzed by nanoLC Orbitrap mass spectrometry. In these samples, we were able to identify peptides derived from the CDRs of adalimumab. These peptides could be detected at an amount of 110 attomole, 5 orders of magnitude lower than the total IgG concentration in these samples. Using higher energy collision induced dissociation (HCD) fragmentation and subsequent de novo sequencing, we could successfully identify 50% of the detectable CDR peptides of adalimumab. In addition, we demonstrated that an affinity purification with anti-dinitrophenol (DNP) monoclonal antibody enhanced anti-DNP derived CDR detection in a serum IgG background. In conclusion, specific CDR peptides could be detected and sequenced at relatively low levels (attomole-femtomole range) which should allow the detection of clinically relevant CDR peptides in patient samples.Keywords
This publication has 20 references indexed in Scilit:
- Immune Responses Are Characterized by Specific Shared Immunoglobulin Peptides That Can Be Detected by Proteomic Techniques*Journal of Biological Chemistry, 2010
- Autoantibodies to tumor‐associated antigens: reporters from the immune systemImmunological Reviews, 2008
- De novo proteomic sequencing of a monoclonal antibody raised against OX40 ligandAnalytical Biochemistry, 2006
- An efficient proteomics-based approach for the screening of autoantibodiesJournal of Immunological Methods, 2005
- De novo sequencing, peptide composition analysis, and composition-based sequencing: A new strategy employing accurate mass determination by fourier transform ion cyclotron resonance mass spectrometryJournal of the American Society for Mass Spectrometry, 2004
- Proteomics Approaches to Identify Tumor Antigen Directed Autoantibodies as Cancer BiomarkersDisease Markers, 2004
- Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesisJCI Insight, 2001
- Somatic insertions and deletions shape the human antibody repertoireJournal of Molecular Biology, 1999
- Somatic generation of antibody diversity.1976
- Reiteration frequency of immunoglobulin light chain genes: further evidence for somatic generation of antibody diversity.Proceedings of the National Academy of Sciences of the United States of America, 1976